about
Complexities of X chromosome inactivation status in female human induced pluripotent stem cells-a brief review and scientific update for autism researchNew Monoclonal Antibodies to Defined Cell Surface Proteins on Human Pluripotent Stem Cells.Prolonged Growth Hormone/Insulin/Insulin-like Growth Factor Nutrient Response Signaling Pathway as a Silent Killer of Stem Cells and a Culprit in Aging.Four simple rules that are sufficient to generate the mammalian blastocystDifferentiation of oligodendrocyte progenitor cells from dissociated monolayer and feeder-free cultured pluripotent stem cellsCharacterization of bovine embryos cultured under conditions appropriate for sustaining human naïve pluripotencyComprehensive Cell Surface Protein Profiling Identifies Specific Markers of Human Naive and Primed Pluripotent StatesNaive Pluripotent Stem Cells Derived Directly from Isolated Cells of the Human Inner Cell MassThe transcriptomes of novel marmoset monkey embryonic stem cell lines reflect distinct genomic features.Wnt/β-catenin signaling promotes self-renewal and inhibits the primed state transition in naïve human embryonic stem cells.Human Embryonic Stem Cells Do Not Change Their X Inactivation Status during Differentiation.Metabolic plasticity complements the unique nature and demands of distinct pluripotency states.Implications for a Stem Cell Regenerative Medicine Based Approach to Human Intervertebral Disk Degeneration.Mechanisms Regulating Stemness and Differentiation in Embryonal Carcinoma Cells.Epigenetic resetting of human pluripotency.Sialylation Is Dispensable for Early Murine Embryonic Development in Vitro.X chromosome inactivation in human pluripotent stem cells as a model for human development: back to the drawing board?How to grow a kidney: patient-specific kidney organoids come of age.Metabolic remodeling during the loss and acquisition of pluripotency.Concise Review: Geminin-A Tale of Two Tails: DNA Replication and Transcriptional/Epigenetic Regulation in Stem Cells.Podocalyxin as a major pluripotent marker and novel keratan sulfate proteoglycan in human embryonic and induced pluripotent stem cells.Formative pluripotency: the executive phase in a developmental continuumThe metabolic programming of stem cells.Decoding the Epigenetic Heterogeneity of Human Pluripotent Stem Cells with Seamless Gene Editing.PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs.New tools for experimental diabetes research: Cellular reprogramming and genome editing.Human Naive Pluripotent Stem Cells Model X Chromosome Dampening and X Inactivation.Regulation of X-chromosome dosage compensation in human: mechanisms and model systems.Principles of early human development and germ cell program from conserved model systems.Podocalyxin as a major pluripotent marker and novel keratan sulfate proteoglycan in human embryonic and induced pluripotent stem cells.Insulin fine-tunes self-renewal pathways governing naive pluripotency and extra-embryonic endoderm.Unique molecular events during reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) at naïve state.Integrated analysis of single-cell embryo data yields a unified transcriptome signature for the human preimplantation epiblast.Naive pluripotent stem cells as a model for studying human developmental epigenomics: opportunities and limitations.Specification of trophoblast from embryonic stem cells exposed to BMP4.Recent advances in lineage differentiation from stem cells: hurdles and opportunities?Pharmacological Regulation of Oxidative Stress in Stem Cells
P2860
Q26745947-52ED364B-1FBF-4C02-A798-4CE4B8657F6BQ33626268-EC7BC8BD-2129-41E7-925E-FAB6535F949DQ33861285-B56287ED-37CD-4B17-BB23-98B6A4DE03D9Q33898314-BA521752-D948-4E01-8A9E-7A4E68D6F3B7Q36278543-5CC87A59-ECAF-4BAD-8BB3-7B30C7B70B95Q36291735-CBBBC271-C29F-4A2E-9B15-B8942CEDE2B2Q36323350-F450E484-5270-437A-AF39-EC3B99AEBB3AQ36805009-DCC30ABA-5A08-4A5F-AF47-24A3B5ACA301Q37072817-59F28A8F-23E8-48E9-9F24-79E6DCEC8031Q37369222-C9411901-7A18-47E0-A7F8-38EB89F9663BQ37559639-6E537422-8E36-4119-9CCA-FDD8A6BECD32Q37678227-07F6026B-9F6E-4487-9CDC-12A9FE0EBB0BQ37683045-7159AC8A-31D2-4F0F-B1A7-82A443FE0DBCQ37714726-119B2BDA-DC1D-4C98-8C04-AA56F2A16898Q38648085-5CFF8DBB-2161-45A0-9420-64407E417276Q38709012-41586409-32A7-4EC2-B940-49404AEBE44EQ38743213-D19F3A02-3229-4DA7-8784-B57D7C1EF263Q38842275-4C3FEBC7-E0C8-4785-BFA5-3D699EF86D19Q38961676-0092A95F-DF93-47C7-B04C-0585B25997E9Q39012400-22AB90B2-CEAE-4B6A-BA32-917F2D48236EQ39081304-0BE8250A-E18F-481B-9187-6019EDFEFF61Q39112403-F83175FE-856A-4FBA-8178-E4E6EA430DF0Q39185375-17816800-3F0C-4C9D-8FEC-171ADD5CA432Q39852752-01D32C5A-FE3A-4E3C-AB48-49B22BED1456Q41689762-B295A043-698E-49BE-9A92-A638995EDF67Q41830358-64082989-E797-439D-B9A4-92096BB213D7Q46398201-1BBE6B52-7B72-43F9-85FE-1E70B384DC66Q46628685-0E5C0959-24B7-4A14-A073-0AC9C26E2901Q47206224-9F12D147-35A8-461E-8461-2CD93C4BDC7FQ47694823-B0905A48-0327-49BF-820A-D8DBB6F86A67Q47748509-C915C29B-AB3C-45B0-A466-7DC49B887C34Q48142719-0C6AE51F-A3B1-4B06-B514-18849E4514E0Q48183332-FFF2F53C-D1A3-4635-9AAB-23738BE8D94BQ50141583-96232A5C-BE79-43FF-90B1-7CBFC43A14C7Q51148958-E68B7E4A-A96E-4898-B97A-E92EF064A501Q55101789-151D9338-D415-4EC0-AA5D-F93F79C8C0A8Q58604365-D0D53743-DFAA-46DF-B90F-CF4EAB7AF982
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
The pluripotent state in mouse and human
@ast
The pluripotent state in mouse and human
@en
The pluripotent state in mouse and human
@nl
type
label
The pluripotent state in mouse and human
@ast
The pluripotent state in mouse and human
@en
The pluripotent state in mouse and human
@nl
prefLabel
The pluripotent state in mouse and human
@ast
The pluripotent state in mouse and human
@en
The pluripotent state in mouse and human
@nl
P3181
P356
P1433
P1476
The pluripotent state in mouse and human
@en
P2093
Kathryn C Davidson
Martin F Pera
P304
P3181
P356
10.1242/DEV.116061
P407
P577
2015-09-15T00:00:00Z